Luke Lavallee

Dr. Luke Lavallee

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
DMDaniel I. McIsaac
Daniel I. McIsaac
EHEmily Hladkowicz
Emily Hladkowicz
GBGregory L. Bryson
Gregory L. Bryson
AFAlan J. Forster
Alan J. Forster
SGSylvain Gagne
Sylvain Gagne
MTMonica Taljaard
Monica Taljaard

1 July 2017 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
KMKristen McAlpine
Kristen McAlpine
RBRodney H. Breau
Rodney H. Breau
RMRanjeeta Mallick
Ranjeeta Mallick
SCSonya Cnossen
Sonya Cnossen
ICIlias Cagiannos
Ilias Cagiannos
LLLuke Lavallee
Luke Lavallee

1 May 2022 in Radiology
Verified
Journal Article
Closed access
UMUr Metser
Ur Metser
KZKatherine Zukotynski
Katherine Zukotynski
VMVictor Mak
Victor Mak
DLDeanna Langer
Deanna Langer
PMPamela MacCrostie
Pamela MacCrostie
GBGlenn Bauman
Glenn Bauman
The detection of additional disease sites at prostate-specific membrane antigen PET in men with biochemical failure after primary therapy and suspected low-volume metastatic disease results in a fr... Background The high positivity rate of prostate-specific membrane antigen (PSMA) PET in the setting of biochemical failure (BCF), even when conventional imaging is negative, is promising. Purpose T...

1 July 2023 in RadioGraphics
Verified
Journal Article
Closed access
WTWendy Tu
Wendy Tu
RGRavi V. Gottumukkala
Ravi V. Gottumukkala
NSNicola Schieda
Nicola Schieda
LLLuke Lavallee
Luke Lavallee
BABenjamin Alexander Adam
Benjamin Alexander Adam
SSStuart G. Silverman
Stuart G. Silverman
Malignancies and other diseases may spread by multiple pathways, including direct extension, hematogenous spread, or via lymphatic vessels. A less-well-understood route is the peripheral nervous system, which is known as perineural spread (PNS). In addition to accounting for pain and other neurologic symptoms, PNS affects both disease prognosis and management. Although PNS is commonly discussed in relation to head and neck tumors, there is emerging data regarding PNS in abdominopelvic malignancies and other conditions such as endometriosis. Due to improved contrast and spatial resolution, perineural invasion, a finding heretofore diagnosed only at pathologic examination, can be detected at CT, MRI, and PET/CT. PNS most commonly manifests as abnormal soft-tissue attenuation extending along neural structures, and diagnosis of it is aided by optimizing imaging parameters, understanding pertinent anatomy, and becoming familiar with the typical neural pathways of spread that largely depend on the disease type and location. In the abdomen, the celiac plexus is a central structure that innervates the major abdominal organs and is the principal route of PNS in patients with pancreatic and biliary carcinomas. In the pelvis, the lumbosacral plexus and inferior hypogastric plexus are the central structures and principal routes of PNS in patients with pelvic malignancies. Although the imaging findings of PNS may be subtle, a radiologic diagnosis can have a substantial effect on patient care. Knowledge of anatomy and known routes of PNS and optimizing imaging parameters is of utmost importance in providing key information for prognosis and treatment planning. © RSNA, 2023 Supplemental material and the slide presentation from the RSNA Annual Meeting are available for this article. Quiz questions for this article are available through the Online Learning Center.

1 November 2019 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
KMKristen McAlpine
Kristen McAlpine
RBRodney H. Breau
Rodney H. Breau
DSDawn Stacey
Dawn Stacey
CKChristopher Knee
Christopher Knee
MJMichael A.S. Jewett
Michael A.S. Jewett
LLLuke Lavallee
Luke Lavallee

16 June 2020 in Canadian Urological Association Journal
Verified
Journal Article
Closed access
KMKristen McAlpine
Kristen McAlpine
RBRodney H. Breau
Rodney H. Breau
DSDawn Stacey
Dawn Stacey
CKChristopher Knee
Christopher Knee
MJMichael A.S. Jewett
Michael A.S. Jewett
LLLuke Lavallee
Luke Lavallee
Introduction: Shared decision-making incorporates patient’s values and preferences to achieve high-quality decisions. The objective of this study was to develop an acceptable patient decision aid to facilitate shared decision-making for the management of small renal masses (SRMs). Methods: The International Patient Decision Aids Standards were used to guide an evidence-based development process. Management options included active surveillance, thermal ablation, partial nephrectomy, and radical nephrectomy. A literature review was performed to provide incidence rates for outcomes of each option. Once a prototype was complete, alpha-testing was performed using a 10-question survey to assess acceptability with patients, patient advocates, urologists, and methodological experts. The primary outcome was acceptability of the decision aid. Results: A novel patient decision aid was created to facilitate shared decision-making for the management of SRMs. Acceptability testing was performed with 20 patients, 10 urologists, two patient advocates, and one methodological expert. Responders indicated the decision aid was appropriate in length (82%, 27 of 33), well-balanced (82%, 27 of 33), and had language that was easy to follow (94%, 31 of 33). All patient responders felt the decision aid would have been helpful during their consultation and would recommend the decision aid for future patients (100%, 20 of 20). Most urologists reported they intend to use the decision aid (90%, 9 of 10). Conclusions: A novel patient decision aid was created to facilitate shared decision-making for management of SRMs. This clinical tool was acceptable with patients, patient advocates, and urologists and is freely available at: https://decisionaid.ohri.ca/decaids.html.